IP Library Patent Application 11885309
Patent Application
App. No. 11/885,309

Process for the Preparation of (R)-4,4-Dialkoxy-Pyran-3-Ols Such as (R)-4,4-Dimethoxy-Pyran-3-Ol

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/885,309
Abstract

The present invention is concerned with novel processes for the preparation of (R)-4,4-dimethoxy-pyran-3-ol. This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity including CCR2 antagonists.

Claims (22)

1 . A process for the preparation of (R)-4,4-dialkoxy-pyran-3-ol of the formula:

which comprises: reacting 4,4-dialkoxy-pyran-3-one of the formula:

where R1 is independently C1-4alkyl, and where R2 is independently C 1 -4alkyl, with a ketone reductase in the presence of nicotinamide adenine dinucleotide phosphate and a cofactor recycling system; to give a (R)-4,4-dialkoxy-pyran-3-ol of the formula:

2 . A process for the preparation of (R)-4,4-dimethoxy-pyran-3-ol of the formula:

which comprises: reacting 4,4-dimethoxy-pyran-3-one of the formula:

with a ketone reductase in the presence of nicotinamide adenine dinucleotide phosphate and a cofactor recycling system; to give (R)-4,4-dimethoxy-pyran-3-ol of the formula:

3 . The process of claim 2 wherein said ketone reductase is selected from KRED101, KRED102, KRED105, KRED107 and KRED 108.

4 . The process of claim 2 wherein the ketone reductase is KRED 101.

5 . The process of claim 2 wherein the ketone reductase is present at a concentration of about 0.095 to 0.105 g/L.

6 . The process of claim 2 wherein the ketone reductase is present at an activity of about 900 U to 1000 U.

7 . The process of claim 2 wherein the substrate 4,4-dimethoxy-pyran-3-one is present at a concentration of about 95 to 105 g/L.

8 . The process of claim 2 wherein the cofactor recycling system comprises glucose and a glucose dehydrogenase.

9 . The process of claim 8 wherein the cofactor recycling system further comprises nicotinamide adenine dinucleotide phosphate.

10 . The process of claim 9 wherein the nicotinamide adenine dinucleotide phosphate is present at a concentration of about 0.12 g/L.

11 . The process of claim 8 wherein glucose is present at a concentration of about 120 to 140 g/L.

12 . The process of claim 8 wherein the glucose dehydrogenase is present at a concentration of about 0.28 to 0.33 g/L.

13 . The process of claim 2 wherein the reaction mixture comprises a phosphate buffer.

14 . The process of claim 2 wherein the reaction mixture further comprises a solvent selected from methanol, ethanol, IPA, acetonitrile and DMSO.

15 . The process of claim 2 comprising the further step of extracting the reaction mixture with a solvent selected from toluene, alcohol, acetonitrile, methyl ethyl ketone, ethyl acetate, isopropyl acetate, and THF.

16 . The process of claim 15 wherein the reaction mixture is extracted with acetonitrile at a temperature of about 20° C. to 30° C.

17 . The process of claim 15 wherein the reaction is extracted with acetonitrile, and wherein the organic layer is dried with toluene.

18 . The process of claim 15 comprising the further step of concentrating the solvent by vacuum distillation.

Assignments (2)
CHANGE OF NAME Recorded Jan 26, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023906/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2008
From: MOORE, JEFFREY C.; KOSJEK, BIRGIT; NTI-GYABAAH, JOSEPH
To: MERCK & CO., INC.
Reel/Frame 020557/0855 →